Abstract
This communication describes the synthesis of a new class of N-hydroxyguanidine (NHG) pro-drugs which release nitric oxide (NO), triggered by the action of gamma-glutamyl transpeptidase (gamma-GT), and have potential for the treatment of acute renal injury/failure (ARI/ARF).
| Original language | English |
|---|---|
| Pages (from-to) | 1389-1391 |
| Number of pages | 3 |
| Journal | Chemical Communications |
| Volume | 49 |
| Issue number | 14 |
| Early online date | 21 Dec 2012 |
| DOIs | |
| Publication status | Published - 2013 |
Keywords
- Nitric-oxide synthases
- Cardiac-surgery
- rat-kidney
- Injury
- Hydroxyguanidines
- Failure
- Oxidation
- Strategy
- Prodrugs
- DOPA